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appear to have subsequently acquired
methicillin resistance through hori-
zontal transfer of SCCmec type IV.
The  spa type of the Italian isolate
comprises 7 nucleotide repeats, indi-
cated by XJ4AKAOM in the alpha-
betical code. This repeat sequence dif-
fers from that of the classical SWP
clone, indicated by XKAKAOMQ
(8), by only 1 bp in the second repeat
and loss of the last Q repeat. In spite
of these differences, the spa type is in
substantial agreement with the MLST
result and indicates that the Italian
isolate is either a descendent or a local
variant of the SWP clone. The most
common clone of CA-MRSA
described in Europe is ST80, spa type
44. CA-MRSA belonging to ST80
tend to be more antimicrobial drug
resistant than isolates belonging to
other clones (4). Resistance to fusidic
acid, typical of ST80, has been pro-
posed as a marker for CA-MRSA in
Europe (10). In light of our finding,
we cannot rely on resistance to fusidic
acid to screen for PVL-producing
CA-MRSA in our country.
To our knowledge, this is the first
report from Italy of necrotizing pneu-
monia caused by PVL-positive CA-
MRSA. The presentation was typical-
ly that of a severe pneumonia that
occurred in a previously healthy,
young adult with no risk factors for
MRSA acquisition, as described in
other cases (11). This is also the first
report of a SWP clone isolate in
southern Europe; if the strain is circu-
lating in Italy or is occasionally
imported from the SWP area, whether
our patient acquired it through contact
with a foreign contact remains
unknown.
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To the Editor: Corvids (crows,
blue jays, magpies, and their rela-
tives) are particularly susceptible to
West Nile virus (WNV) (1). Birds are
useful indicators of the spread of
WNV (1), and Canada has imple-
mented WNV surveillance strategies
that use these species as sentinels. 
Direct acquisition of WNV
through percutaneous injuries has
been reported in 2 laboratory circum-
stances, involving a blue jay and a
mouse (2). We describe a conjunctival
exposure to WNV that occurred in the
field and probably resulted in infec-
tion in the exposed person.
As part of the local WNV bird sur-
veillance activities in 2003, an animal
control officer collected sick and dead
corvids at the Canadian Forces Base,
Suffield, Alberta. He had a protective
suit on, but he wore no mask or face
shield. While killing an injured crow
(Corvus brachyrhynchos), the officer
struck the struggling bird on a nearby
horizontal pipe gate, which resulted in
fracture of the skull, causing brain tis-
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sue and cerebrospinal fluid to spray
onto his head, face, neck, and right
shoulder. Body fluids and brain mate-
rial of the bird entered his eyes, but
not his mouth; he had no known open
lesions on the exposed area. His co-
workers immediately wiped off visi-
ble material, and a few hours later he
showered.
The dead crow was sent for analy-
sis to the Fish and Wildlife Division,
Government of Alberta, where labora-
tory tests using the VecTest assay
(Medical Analysis Systems, Inc.,
Camarillo, CA, USA), indicated that
the crow was positive for WNV anti-
gen. This test has been validated for
detecting viral antigen in oropharyn-
geal and cloacal swabs in crows (3).
Seven days after exposure, the ani-
mal control officer became unwell
and sought medical assistance. His
symptoms included headaches, dizzi-
ness, spiking fevers, and sweats; on
examination, mild otitis was noted,
but he did not display meningismus or
other neurologic signs. Awhole blood
sample with EDTA and a serum sam-
ple were collected, together with a
throat swab for viral culture to
exclude a possible enteroviral infec-
tion, as part of a standardized provin-
cial protocol for investigating sus-
pected WNV infections in Alberta.
Betahistine dihydrochloride was pre-
scribed for the dizziness and a
cephalosporin for otitis. A cere-
brospinal fluid sample was not col-
lected, since his clinical signs did not
suggest neurologic involvement.
At the Provincial Laboratory,
WNV RNA was detected in the plas-
ma by nucleic acid sequence-based
amplification, with primers described
by Lanciotti and Kerst (4), which was
confirmed by the Artus RealArt RT-
PCR assay (artus biotech USA Inc,
San Francisco, CA, USA) in a Roche
LightCycler. The serum sample, col-
lected at the same time as the plasma
sample, was negative for immuno-
globulin M (IgM) antibody by
enzyme immunoassay using 2 kits
(Panbio, Windsor, Queensland,
Australia; and Focus Technologies,
Cypress, CA, USA). Fourteen days
after exposure, a convalescent-phase
serum sample showed IgM antibody
to WNV in both kits; the plasma sam-
ple was negative for viral RNA.
Hemagglutination inhibition assay on
the acute- and convalescent-phase
serum samples, collected 7 days apart,
showed rising titers, from <1:10 on
the acute-phase serum, to 1:40 for
dengue virus (serotypes 1–4), 1:40 for
St. Louis encephalitis virus, and 1:80
for WNV on the convalescent-phase
serum. Preliminary data from our lab-
oratory indicate that in ≈40% of cases
of acute West Nile fever, the acute-
phase plasma sample shows viral
RNA before IgM antibody develops,
after which viral RNA is no longer
detectable (J. Fox, unpub. data). Two
weeks after culture was initiated for
virus isolation, the throat swab was
negative for enteroviruses.
The patient’s severe fever, sweats,
headaches, anorexia, fatigue, and
diminished concentration and memo-
ry continued. His symptoms peaked 2
weeks after the initial exposure. Three
months later, his symptoms of fatigue,
dizziness, headaches, and poor mem-
ory were severe enough to prevent
him from returning to fulltime work.
Eight months after exposure, he con-
tinues to have fatigue and headaches.
We believe this is the first reported
case of apparent conjunctival trans-
mission of WNV in an occupational
setting. As the officer spent consider-
able time outdoors in areas where
WNV transmission was relatively
high in 2003 and repeatedly handled
infected birds, we cannot eliminate
the possibility of a mosquito bite or
other percutaneous route of transmis-
sion. However, the nature of the expo-
sure and the time to symptom devel-
opment strongly suggest that infection
occurred after conjunctival exposure.
Persons who dispatch sick wildlife are
encouraged to use appropriate,
humane methods and should take pre-
cautions against exposure to tissues
and body fluids. 
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